126 related articles for article (PubMed ID: 38513200)
1. Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.
van Dantzig P; Quincey V; Kurz J; Ming C; Kamalaksha S; White D
N Z Med J; 2024 Mar; 137(1592):14-21. PubMed ID: 38513200
[TBL] [Abstract][Full Text] [Related]
2. Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand.
van Dantzig P; White D; Kurz J; Ming C; Kamalaksha S; Quincey V
N Z Med J; 2024 Mar; 137(1592):31-42. PubMed ID: 38513202
[TBL] [Abstract][Full Text] [Related]
3. Re: Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.
Modesto Dos Santos V; Arruda Modesto Sugai T
N Z Med J; 2024 Apr; 137(1593):93-95. PubMed ID: 38603793
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
5. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
Mohammad AJ; Nilsson JÅ; Jacobsson LT; Merkel PA; Turesson C
Ann Rheum Dis; 2015 Jun; 74(6):993-7. PubMed ID: 24442881
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of biopsy-proven giant cell arteritis in South Australia.
Dunstan E; Lester SL; Rischmueller M; Dodd T; Black R; Ahern M; Cleland LG; Roberts-Thomson P; Hill CL
Intern Med J; 2014 Jan; 44(1):32-9. PubMed ID: 24118799
[TBL] [Abstract][Full Text] [Related]
7. The incidence of giant cell arteritis in Slovenia.
Pucelj NP; Hočevar A; Ješe R; Rotar Ž; Hawlina M; Fakin A; Pižem J; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):285-290. PubMed ID: 30062445
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis.
Abdul-Rahman AM; Molteno AC; Bevin TH
N Z Med J; 2011 Feb; 124(1329):44-52. PubMed ID: 21475359
[TBL] [Abstract][Full Text] [Related]
9. Giant cell arteritis in Asians: a comparative study.
Pereira LS; Yoon MK; Hwang TN; Hong JE; Ray K; Porco T; McCulley TJ
Br J Ophthalmol; 2011 Feb; 95(2):214-6. PubMed ID: 20584707
[TBL] [Abstract][Full Text] [Related]
10. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
González-Gay MA; Garcia-Porrua C; Rivas MJ; Rodriguez-Ledo P; Llorca J
Ann Rheum Dis; 2001 Apr; 60(4):367-71. PubMed ID: 11247867
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data.
Mahr A; Belhassen M; Paccalin M; Devauchelle-Pensec V; Nolin M; Gandon S; Idier I; Hachulla E
Rheumatology (Oxford); 2020 Jan; 59(1):120-128. PubMed ID: 31382293
[TBL] [Abstract][Full Text] [Related]
13. Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand.
Lyne SA; Ruediger C; Lester S; Chapman PT; Shanahan EM; Hill CL; Stamp L
Front Med (Lausanne); 2022; 9():1057917. PubMed ID: 36482913
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features.
González-Gay MA; Blanco R; Sánchez-Andrade A; Vázquez-Caruncho M
J Rheumatol; 1997 Nov; 24(11):2166-70. PubMed ID: 9375879
[TBL] [Abstract][Full Text] [Related]
15. Giant cell arteritis: epidemiology, diagnosis, and management.
Gonzalez-Gay MA; Martinez-Dubois C; Agudo M; Pompei O; Blanco R; Llorca J
Curr Rheumatol Rep; 2010 Dec; 12(6):436-42. PubMed ID: 20857242
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate.
Stamatis P; Turkiewicz A; Englund M; Turesson C; Mohammad AJ
Rheumatology (Oxford); 2021 Dec; 61(1):146-153. PubMed ID: 33742665
[TBL] [Abstract][Full Text] [Related]
17. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
[TBL] [Abstract][Full Text] [Related]
18. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
[TBL] [Abstract][Full Text] [Related]
19. Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018.
Kønig EB; Stormly Hansen M; Foldager J; Siersma V; Loft A; Terslev L; Møller Døhn U; Radmer Jensen M; Wiencke AK; Faber C; Hamann S; Heegaard S
Acta Ophthalmol; 2021 Aug; 99(5):527-532. PubMed ID: 33211398
[TBL] [Abstract][Full Text] [Related]
20. Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis.
Pouncey AL; Yeldham G; Magan T; Lucenteforte E; Jaffer U; Virgili G
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD013199. PubMed ID: 38323659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
